Speyer, J L <br/><br/>
Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.  [electronic resource] 

 -  The New England journal of medicine  Sep 1988 
 - 745-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM198809223191203  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Tolerance<br/>Female<br/>Fluorouracil--administration & dosage<br/>Heart--diagnostic imaging<br/>Heart Failure--chemically induced<br/>Humans<br/>Middle Aged<br/>Myocardium--pathology<br/>Piperazines--therapeutic use<br/>Radionuclide Imaging<br/>Random Allocation<br/>Razoxane--administration & dosage<br/>Stroke Volume